Structure of YOLOv5s-SBC. by Zhongjian Xie (4633099)

“…Compared to the original model, P-YOLOv5s-GRNF decreased parameters by 18%, decreased model size to 11.9MB, decreased FLOPs to 14.5G, and increased FPS by 4.3. …”

Changes in neural activity were decreased in animals pre-exposed to 5-HT and <i>mod-1</i> mutants when the worms switched their locomotive direction. by Haruka Mori (8082215)

“…<p>(A–F) the neural activity of the RID changes during the transition periods from backward to forward locomotion (A–C) and from forward to backward locomotion (D–F) in the mock (A: p = 1.5 × 10⁻⁵; D: p = 5.5 × 10⁻¹³), 5-HT exposed (B: p = 0.092; E: p = 0.79), and <i>mod-1</i> mutant (C: p = 0.081; F: p = 0.93) groups. …”

Luciferase reporter expression analysis in A427-derived xenograft tumors following IT injection of rH17d’-Ad5 vectors. by Christopher M. Gentile (6640331)

Decreased expression of RRIowa_1520 by <i>R. rickettsii</i> Iowa. by Adam M. Nock (16715671)

Fig 5 - by Mísia Helena da Silva Ferro (20623666)

Fig 5 - by Jeannette Silva-López (16541854)

Fig 5 - by Simon Taub (12262035)

2‑Ethylhexyl Diphenyl Phosphate and Its Hydroxylated Metabolites are Anti-androgenic and Cause Adverse Reproductive Outcomes in Male Japanese Medaka (Oryzias latipes) by Yu Li (183836)

“…In this study, we for the first time observed that EHDPP elicited androgen receptor (AR) antagonistic activity with a 50% inhibitory concentration of 37.5 μM. 2-Ethyl-5-hydroxyhexyl diphenyl phosphate was proved to be the dominant metabolite of EHDPP in Japanese medaka and elicited 3.1-fold stronger AR antagonistic activity than that of EHDPP. …”

2‑Ethylhexyl Diphenyl Phosphate and Its Hydroxylated Metabolites are Anti-androgenic and Cause Adverse Reproductive Outcomes in Male Japanese Medaka (Oryzias latipes) by Yu Li (183836)

“…In this study, we for the first time observed that EHDPP elicited androgen receptor (AR) antagonistic activity with a 50% inhibitory concentration of 37.5 μM. 2-Ethyl-5-hydroxyhexyl diphenyl phosphate was proved to be the dominant metabolite of EHDPP in Japanese medaka and elicited 3.1-fold stronger AR antagonistic activity than that of EHDPP. …”

Decreasing trends in HbA1c are visible when using the average HbA1c for each dataset for T1Ds, but not T2Ds. by Hans F. Dias (14486401)

RNF5 depletion suppresses PEL xenograft tumor growth and decreases the levels of cell cycle gene expression and hedgehog signaling in tumors. by Xiaojuan Li (351842)

<i>IXR1</i> deletion restored the decreased expression of <i>CLB1</i> caused by <i>PUF5</i> deletion. by Megumi Sato (4116994)

Nicotine decreased Akt phosphorylation in SK-BR-3 cells. by Masanori A. Murayama (5774585)

MVEC viability is decreased over time in PEG-based hydrogels. by Rebecca A. Scott (488956)

Knockout of <i>PDLIM2</i> results in increased STAT2 upon interferon treatment, decreased association with ubiquitin and increased nuclear retention. by Michael A. Joyce (267535)

Data_Sheet_1_Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia.docx by Nicholas Reyes (16390233)

Data_Sheet_2_Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia.docx by Nicholas Reyes (16390233)

Data_Sheet_1_Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia.docx by Nicholas Reyes (16390233)

Data_Sheet_2_Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia.docx by Nicholas Reyes (16390233)

19606 decreases the luminal pH of the ACV during infection. by Jesus S. Distel (11250759)